GeneGlobe ID: UHS-006Z | Cat. No.: | QIAseq Multimodal Panels

QIAseq Multimodal Human Sarcoma Panel

Kit containing ALL reagents (except indexes) for multimodal (DNA and RNA) sequencing

Select a variant to see the price

Product Specification

Target List

Alveolar Soft Part Sarcomas
APC, CDH1 (E-Cadherin), KMT2D, NTRK3, PTEN, TP53 (p53), ASPSCR1, TFE3
Angiosarcomas & Epitheliod Haemangioendotheliomas
AKT1, ALK, APC, AR, ARID1A, ARID1B, ARID2, ASXL1, ATM, ATR, ATRX, BRAF, BRCA1, BRCA2, CASP8 (FLICE), CDKN2A (P16INK4A), CIC, CREBBP (CBP), CSMD3, CTNNB1, DCC, EGFR (ERBB1), EP300, EPHA3, EPHA7, ERBB2 (HER-2, NEU), ERBB3, ERBB4, EZH2, FAT1, FBXW7, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, FLT4 (VEGFR2), HRAS, JAK3, KDM6A, KDR (VEGFR3), KMT2D, KRAS, LRP1B, MED12, MET, MLH1, MPL, MSH2, MTOR, MUC16, NBEA, NCOR1, NF1, NOTCH2, NRAS, NSD1, NTRK3, PAX5, PBRM1, PDGFRB, PIK3CA (p110-alpha), PIK3CB, PIK3R1 (p85-ALPHA), PLCG1, PRDM1, PREX2, PTCH1, PTEN, PTPRB, PTPRD, PTPRT, ROS1, SETD2, SMARCD1, TERT, TGFBR2, TP53 (p53), TRAF7, TRRAP, TSC1, TSC2, ZFHX3, CAMTA1, CEP85L, CIC, LEUTX, ROS1, TFE3, YAP1
Chondrosarcomas
AKAP9, ALK, AR, ARID1A, ATRX, CACNA1D, CAMTA1, CDKN2A (P16INK4A), CNTNAP2, COL2A1, DNMT3A, EED, EPHA3, EPHA7, ERBB3, ERBB4, FLT4 (VEGFR2), H3-3A, HRAS, IDH1, IDH2, IRS4, JAK1, KDM6A, KDR (VEGFR3), KMT2D, LRP1B, MLLT3, MUC16, MUTYH, MYH9, NF2, NRAS, PALB2, POLE, PTCH1, PTEN, PTPRB, PTPRT, RB1, ROS1, SDHA, SETD2, SMAD2 (MADH2), SMARCB1, SUFU, TERT, TET2, TP53 (p53), TSC1, ZFHX3, ACVR2A, CDX1, EWSR1, FN1, HEY1, IRF2BP2, NCOA2, NR4A3 (NOR1), TAF15, TCF12, TFG
Chordomas
ALK, APC, AR, ARID1A, ATM, CBL, CDKN2A (P16INK4A), CTNNB1, KDR (VEGFR3), KIT (CD117), KMT2A, KMT2D, NRAS, PIK3CA (p110-alpha), PTEN, SETD2, SMARCB1, TP53 (p53)
Clear Cell Sarcomas
BRAF, CDKN2A (P16INK4A), EGFR (ERBB1), NRAS, PTEN, TP53 (p53), ATF1, CREB1, EWSR1, FLI1, NUTM2B, YWHAE
Dermatofibrosarcoma Protuberans
FGFR1, MED12, NF1, TGFBR2, COL1A1, PDGFB
Desmoplastic Small Round Cell Tumors
APC, CIC, CREBBP (CBP), DAXX, EGFR (ERBB1), EP300, EPHA3, KMT2C, MTOR, ROS1, SMARCA4, TET2, ERG, EWSR1, FLI1, PATZ1, WT1
Endometrial Stromal Sarcomas
ASXL1, CTNNB1, DCC, ERBB3, FBXW7, FGFR2, FLT3, KMT2C, KRAS, MED12, PIK3CA (p110-alpha), PTCH1, TP53 (p53), ALK, BCOR, CXorf67, EPC1, FN1, JAZF1, MBTD1, MEAF6, NUTM2A, NUTM2B, PHF1, SUZ12, YWHAE, ZC3H7B
Epithelioid Sarcomas
DICER1, SMARCB1, TET2, TGFBR2, CREB3L1, CREB3L2, EWSR1, FUS, KLF17, SS18, SSX1
Ewing Sarcomas
AFF3, AKAP9, ALK, APC, AR, ARID1A, ARID1B, ARID2, ASXL1, ATM, ATR, ATRX, BCOR, BIRC6, BRAF, BRCA1, BRCA2, CACNA1D, CAMTA1, CARD11, CBL, CD209, CD79B, CDH1 (E-Cadherin), CDKN2A (P16INK4A), CHD4, CIC, CLTCL1, COL2A1, COL3A1, CREBBP (CBP), CSMD3, CTNNB1, DAXX, DCC, DDX10, DGCR8, DICER1, DNMT3A, EED, EGFR (ERBB1), EP300, EPHA3, EPHA7, EPS15, ERBB2 (HER-2, NEU), ERBB4, ERCC5, EZH2, FAM131B, FAM47C, FANCA, FAT1, FAT4, FBXW7, FGFR1, FGFR3, FGFR4, FLNA, FLT4 (VEGFR2), GNAS, GRIN2A, HNF1A, HRAS, IDH1, IDH2, IRS4, KDR (VEGFR3), KIT (CD117), KMT2A, KMT2C, KMT2D, KRAS, LRP1B, MAML2, MED12, MET, MLH1, MLLT3, MSH2, MTOR, MUC16, MUC4, MUTYH, MYH9, MYOD1, NCOR1, NCOR2, NF1, NF2, NOTCH1, NOTCH2, NPM1, NRAS, NSD1, NTRK3, PALB2, PAX5, PBRM1, PDGFRB, PIK3CA (p110-alpha), PIK3CB, PIK3R1 (p85-ALPHA), PLCG1, PML, POLE, PRDM1, PRDM2 (RIZ1), PREX2, PTCH1, PTEN, PTPN13, PTPRB, PTPRD, PTPRT, RB1, RECQL4, ROS1, SDHA, SETD2, SMARCA4, SMARCB1, SPEN, STAG2, SUFU, TERT, TET2, TNC, TOP1, TP53 (p53), TRAF7, TRRAP, TSC1, TSC2, XPC, ZFHX3
Fibrosarcomas
ATRX, BCOR, BRCA1, CDKN2A (P16INK4A), CTNNB1, EGFR (ERBB1), EZH2, FGFR3, FLT3, FOXP1, KDM6A, KDR (VEGFR3), KIT (CD117), KRAS, NF1, NF2, NRAS, POLE, PTEN, RB1, TERT, TP53 (p53), TRAF7, BRAF, COL1A1, CREB3L1, CREB3L2, EWSR1, FUS, LMNA, NTRK1, PDGFB, TOM1L2
Gastrointestinal Stromal Tumors (GIST)
ALK, APC, AR, ARID1A, ARID1B, ARID2, ASXL1, ATR, ATRX, BRAF, BRCA2, CARD11, CBL, CDH1 (E-Cadherin), CDKN2A (P16INK4A), CHD4, CREBBP (CBP), DAXX, DICER1, EGFR (ERBB1), EP300, EPHA7, ERBB4, FAT1, FBXW7, FGFR1, FLT4 (VEGFR2), FOXP1, H3-3A, HNF1A, JAK1, KDM6A, KDR (VEGFR3), KIT (CD117), KMT2A, KMT2C, KMT2D, KRAS, MED12, MSH2, MTOR, MYOD1, NF1, NF2, NOTCH1, NOTCH2, PBRM1, PDGFRA, PDGFRB, PIK3CA (p110-alpha), POLE, PTCH1, PTEN, PTPRT, RB1, RECQL4, ROS1, SDHA, SETD2, SH2B3, SPEN, TERT, TET2, TGFBR2, TP53 (p53), TRAF7, TSC1, TSC2, ZFHX3
Kaposi Sarcomas
BRAF, PIK3CA (p110-alpha), TP53 (p53)
Leiomyosarcomas
ALK, APC, AR, ARID1A, ARID1B, ARID2, ASXL1, ATM, ATR, ATRX, BRCA1, BRCA2, BRD4, CARD11, CBL, CDH1 (E-Cadherin), CREBBP (CBP), DAXX, DNMT3A, EED, EP300, EPHA3, ERBB3, ERBB4, ERCC5, EZH2, FGFR1, FGFR3, FOXP1, GRIN2A, JAK1, JAK3, KDM6A, MET, MPL, MSH2, NCOR1, NF2, NPM1, PAX5, RECQL4, TGFBR2, TOP1, TRAF7, EWSR1, PBX3, WT1
Liposarcomas
AKT1, ALK, APC, ARID1A, ARID1B, ATM, ATRX, BRAF, BRCA2, BRD4, CBL, CD79B, CDH1 (E-Cadherin), CDKN2A (P16INK4A), CIC, COL3A1, CTNNB1, DICER1, DNMT3A, EGFR (ERBB1), EP300, ERBB2 (HER-2, NEU), ERBB4, FAT1, FAT4, FBXW7, FGFR1, FGFR2, FGFR3, FOXP1, HRAS, JAK1, JAK3, KDM6A, KDR (VEGFR3), KIT (CD117), KMT2A, KMT2C, KMT2D, KRAS, MAML2, MLH1, MPL, MUTYH, NCOR1, NF1, NF2, NOTCH2, NSD1, PBRM1, PDGFRA, PIK3CA (p110-alpha), PIK3R1 (p85-ALPHA), POLE, PRDM1, PTEN, RB1, RECQL4, ROS1, SDHA, SETD2, SMARCA4, TERT, TET2, TP53 (p53), TSC1, ZFHX3, DDIT3 (GADD153, CHOP), EWSR1, FUS, LGR5, NUP107
Malignant Peripheral Nerve Sheath Tumors (MPNST)
ARID2, BCOR, BIRC6, BRAF, BRCA1, CBL, CDKN2A (P16INK4A), EED, FAT1, KRAS, NF1, NRAS, PAX5, PDGFRA, STAG2, TERT, TP53 (p53)
Osteosarcomas
AKT1, ALK, APC, AR, ARID1A, ASXL1, ATR, ATRX, BCOR, BRAF, BRCA1, BRCA2, BRD4, CACNA1D, CAMTA1, CARD11, CBL, CD209, CDH1 (E-Cadherin), CDKN2A (P16INK4A), CHD4, CLTCL1, COL2A1, CREBBP (CBP), CSMD3, DAXX, DCC, DDX10, DNMT3A, EGFR (ERBB1), EP300, EPHA7, ERBB4, FAM47C, FANCA, FAT4, FBXW7, FGFR3, FGFR4, FLNA, FLT3, FOXP1, GNAS, GRIN2A, H3-3A, IDH2, JAK1, JAK3, KDR (VEGFR3), KMT2A, KMT2C, KMT2D, LRP1B, MED12, MET, MLH1, MLLT3, MUC16, MUC4, NBEA, NCOR1, NCOR2, NF1, NF2, NOTCH2, NPM1, NTRK3, PAX3, PBRM1, PDGFRB, PIK3CA (p110-alpha), PIK3CB, PIK3R1 (p85-ALPHA), POLE, PRDM1, PRDM2 (RIZ1), PREX2, PTCH1, PTEN, PTPRD, PTPRT, RB1, RECQL4, ROBO2, ROS1, SDHA, SETD2, SMAD2 (MADH2), SMARCA4, SPEN, STAG2, SUFU, TERT, TET2, TGFBR2, TNC, TP53 (p53), TRRAP, TSC1, TSC2, WNK2, XPC, ZFHX3
Perivascular Epithelioid Cell Tumors (PEComa)
ALK, ATM, ATRX, CIC, JAK3, KDM6A, MED12, NOTCH2, NTRK3, RB1, SDHA, TP53 (p53), TSC1, TSC2, DVL2, SFPQ, TFE3
Pleomorphic Sarcomas (Malignant Fibrous Histiocytoma)
ALK, APC, AR, ARID1A, ARID1B, ARID2, ASXL1, ATM, ATR, ATRX, BRAF, BRCA1, BRCA2, BRD4, CARD11, CASP8 (FLICE), CD79B, CDKN2A (P16INK4A), CIC, CTNNB1, DICER1, DNMT3A, EGFR (ERBB1), EP300, EPHA3, ERBB2 (HER-2, NEU), ERBB3, ERBB4, EZH2, FANCA, FAT1, FBXW7, FGFR1, FGFR4, FLT3, FOXP1, GRIN2A, HRAS, IDH1, JAK1, JAK3, KIT (CD117), KMT2A, KMT2C, KMT2D, KRAS, MET, MLH1, MSH2, MTOR, MUTYH, MYOD1, NCOR1, NF1, NF2, NOTCH1, NOTCH2, NPM1, NRAS, NSD1, NTRK3, PALB2, PAX5, PBRM1, PDGFRB, PIK3CA (p110-alpha), POLE, PRDM1, PTCH1, PTEN, PTPN11, PTPRD, PTPRT, RB1, ROS1, SETD2, SMARCA4, SMARCB1, SUFU, TERT, TET2, TGFBR2, TOP1, TP53 (p53), TRAF7, TSC2, ZFHX3, CITED2, MED12, PRDM10
Rhabdoid Tumors
CREBBP (CBP), KDM6A, KMT2C, MUC16, PBRM1, SETD2, SMARCA4, SMARCB1, TSC2, NCOA4, RET
Rhabdomyosarcomas
AFF3, AKAP9, ALK, APC, AR, ARID1A, ARID1B, ARID2, ASXL1, ATM, ATR, ATRX, BCOR, BRAF, BRCA1, BRCA2, CASP8 (FLICE), CDKN2A (P16INK4A), CHD4, CIC, CLTCL1, CNTNAP2, COL2A1, CREBBP (CBP), CSMD3, CTNNB1, DAXX, DCC, DGCR8, DICER1, DNMT3A, EP300, EPHA3, EPHA7, EPS15, ERBB2 (HER-2, NEU), ERBB3, ERCC4, ERCC5, EZH2, FAM131B, FAM47C, FANCA, FAT1, FAT4, FBXW7, FGFR1, FGFR2, FGFR3, FGFR4, FLNA, FLT3, FLT4 (VEGFR2), FOXP1, GNAS, GRIN2A, HNF1A, HRAS, IRS4, KDM6A, KDR (VEGFR3), KIT (CD117), KMT2C, KMT2D, KRAS, LRP1B, MAML2, MED12, MET, MLH1, MPL, MSH2, MTOR, MUC16, MUTYH, MYH9, MYOD1, NBEA, NCOR2, NF1, NOTCH1, NOTCH2, NRAS, NSD1, NTRK3, PALB2, PDGFRA, PDGFRB, PIK3CA (p110-alpha), PML, POLE, PRDM1, PRDM2 (RIZ1), PREX2, PTCH1, PTEN, PTPN11, PTPN13, PTPRT, RECQL4, ROBO2, ROS1, SETD2, SFRP4, SH2B3, SMARCA4, SMARCB1, TET2, TNC, TP53 (p53), TRAF7, TRRAP, TSC1, TSC2, WNK2, XPC, ZFHX3, CITED2, EWSR1, FLI1, FOXO1, NCOA1, NCOA2, PAX3, PAX7, SRF, TEAD1, VGLL2
Solitary Fibrous Tumors
ALK, APC, ARID2, CBL, EP300, ERBB4, FAT1, FBXW7, FGFR1, FGFR3, KMT2D, NF1, NSD1, PIK3R1 (p85-ALPHA), PTEN, SPEN, SUFU, TERT, TP53 (p53), NAB2, STAT6
Synovial Sarcomas
ARID1B, ARID2, BCOR, BRAF, CDH1 (E-Cadherin), CTNNB1, EGFR (ERBB1), ERBB4, FGFR1, FLT4 (VEGFR2), HRAS, KDR (VEGFR3), KMT2A, KMT2C, KMT2D, KRAS, MED12, MLH1, PALB2, PDGFRA, PIK3CA (p110-alpha), PIK3R1 (p85-ALPHA), PRDM1, PTEN, SETD2, TERT, TP53 (p53), TRAF7, TRRAP, ZFHX3, COL6A3, CSF1 (MCSF), S100A10, SS18, SS18L1, SSX1, SSX2, SSX4
Undifferentiated; Unclassified or Other Sarcomas
ARID2, ATM, ATRX, BRCA2, CIC, CREBBP (CBP), CTNNB1, DICER1, EED, EGFR (ERBB1), EPHA7, FBXW7, FLT3, FOXP1, H3-3A, HNF1A, KDM6A, MED12, MET, NCOR1, NOTCH2, NSD1, PALB2, PBRM1, PTCH1, PTPRD, ROS1, SH2B3, SPEN, STAG2, SUFU, TP53 (p53), ATF1, BCOR, CCNB3, CREM, ERG, ETV4, EWSR1, FGF1, FGFR1, FLI1, FN1, FOXO1, FUS, JAZF1, MAML3, PAX3, POU5F1 (OCT4), RUNX1 (AML1), RUNX1T1, SUZ12
Askins Tumors
ERG, EWSR1, FLI1, FUS
Chondrosarcomas; Myxoid
NR4A3 (NOR1), TAF15
Congenital (Infantile) Fibrosarcomas
ETV6, MET, NTRK3, TFG
Ewing's Sarcomas
CIC, ERG, ETV1, ETV4, EWSR1, FEV, FLI1, FOXO4, FUS, NFATC2, SMARCA5, SP3
Myofibroblastic Sarcomas
ALK, LMNA, NTRK1, RELA, ROS1, SRF, TFG, TPM3, YWHAE
Other Sarcomas
ALK, ASPSCR1, COL1A1, DDIT3 (GADD153, CHOP), ETV6, EWSR1, FOXO1, FUS, GLI1, HMGA2, LMNA, MKL2, NPM1, NTRK1, NTRK3, PAX3, PAX7, PDGFB, PLAG1, SS18, SSX1, SSX2, TFE3, USP6, WT1

Product Resources

Detailed Target List for each Analyte
File Size: 19.35 KBLanguage: English

Resources

Brochures & Guides (4)
State-of-the-art technologies to fast-track and streamline NGS workflows
QIAseq Multimodal Analytical Technology
QIAseq Multimodal: The power of one
Supplementary Files (1)
List of gene targets for QIAseq Pan-cancer Multimodal Panel
Safety Data Sheets (1)
Certificates of Analysis (1)
Introducing the QIAseq Multimodal Human Sarcoma Panel, a cutting-edge addition to our QIAseq Multimodal Panels lineup, specifically designed for NGS applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the QIAseq Multimodal Human Sarcoma Panel facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting NGS, or any other sophisticated analyses, this product from our QIAseq Multimodal Panels collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with QIAseq Multimodal Human Sarcoma Panel and elevate your work to new heights.